1 most recent filing and news item mentioning EFSM. Updated every 60 seconds.
EarningsJul 20, 2026Positive
Evofem Biosciences reported positive market performance in its fifth commercial quarter post-lavien approval, highlighting continued commercial traction and operational milestones.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.